Skip to main content
. 2019 Jun 28;62(14):6615–6629. doi: 10.1021/acs.jmedchem.9b00454

Table 1. Data Collection and Refinement Statistics.

  MsCI4·4a MsCI4·4b MsCI4·5a MsCI4·5b MsCI4·7a MsCI4·7b MsCI4·7c MsCI4·7d MsCI4·7f
Data Collection
space group P212121 P212121 P212121 P212121 P212121 P212121 P212121 P21 P212121
Unit Cell
a, b, c (Å) 56.46, 58.82, 88.23 56.75, 58.82, 88.57 56.95, 59.58, 89.05 56.66, 58.71, 88.01 56.33, 58.68, 89.27 56.42, 58.80, 88.23 56.33, 58.68, 89.27 31.63, 52.39, 59.29 56.87, 58.55, 88.28
α, β, γ (deg) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90.0, 95.8, 90.0 90, 90, 90
resolution range, Å 44.1–1.55 (1.64–1.55) 44.28–1.6 (1.7–1.6) 44.53–1.7 (1.8–1.7) 47.64–1.75 (1.85–1.75) 49.03–1.8 (1.86–1.8) 48.93–1.73 (1.84–1.73) 49.03–1.85 (1.96–1.85) 39.2–1.1 (1.16–1.1) 44.14–1.65 (1.75–1.65)
redundancy 12.7 (11.8) 12.9 (12.9) 12.4 (12.8) 12.8 (12.8) 12.86 (12) 12.5 (12.0) 12.9 (13.0) 6.3 (5.3) 12.9 (13.2)
completeness % 99.8 (98.9) 99.9 (99.4) 99.0 (98.2) 99.6 (97.7) 99.6 (97.6) 98.8 (92.4) 99.8 (98.6) 99.1 (95.1) 99.9 (99.6)
R merge % 9.0 (98.2) 5.3 (82.8) 7.3 (94.6) 6.6 (98.5) 7.2 (89.0) 14.2 (88.8) 6.1 (102.8) 5.3 (39.4) 6.9 (81.5)
CC (1/2) 99.9 (85.4) 100 (90.4) 99.9 (87.8) 100 (87.6) 100 (84.6) 99.6 (85.7) 99.9 (78.1) 99.8 (92.4) 99.9 (86.6)
I/s(I) 15.09 (1.78) 15.09 (1.78) 20.22 (2.02) 20.47 (2.27) 22.12 (2.39) 10.55 (1.73) 21.46 (2.25) 17.67 (3.64) 20.72 (2.35)
Refinement
number of reflections (total/test) 43 370 (4254) 39 841 (3904) 33 803 (3354) 30 301 (2985) 28 122 (2771) 30 582 (2948) 28 122 (2771) 77 822 (7458) 36 182 (3558)
no. of atoms 2871 2787 2767 2709 2544 2778 2675 2082 2464
protein 2572 2519 2504 2523 2338 2521 2468 1768 2229
solvent 223 173 185 134 175 187 123 276 166
ligand 76 95 78 52 31 70 84 38 69
R work % 0.17 0.19 0.18 0.19 0.17 0.17 0.18 0.12 0.20
R free % 0.20 0.22 0.23 0.23 0.22 0.23 0.22 0.15 0.22
Ligand in Chain
A thalidomide hydrolyzed 4b thalidomide 5b 7a thalidomide 7c   thalidomide
B 4a hydrolyzed 4b hydrolyzed 5a 5b 7a 7b 7c co-crystal with 7d 7f
C hydrolyzed 4a hydrolyzed 4b 5a     thalidomide 7c    
PDB ID 6R0S 6R0V 6R0U 6R11 6R1X 6R12 6R1K 6R1D 6R13
  MsCI4·11a MsCI4·12a MsCI4·16b MsCI4·20a MsCI4·20b MsCI4·CBG      
Data Collection      
space group P212121 P212121 P212121 P212121 P212121 P21      
Unit Cell      
a, b, c (Å) 56.63, 59.59, 88.90 56.66, 59.02, 88.59 56.53, 59.44, 88.36 56.56, 59.23, 88.43 56.56, 59.3, 88.0 61.7, 59.1, 61.7      
α, β, γ (deg) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 105.6, 90      
resolution range, Å 44.45–1.35 (1.43–1.35) 49.12–1.5 (1.59–1.5) 47.62–1.35 (1.43–1.35) 49.21–1.45 (1.50–1.45) 49.18–1.54 (1.64–1.54) 49.17–1.50 (1.59–1.50)      
redundancy 12.7 (12.4) 12.6 (12.6) 12.6 (12.7) 12.8 (12.9) 12.6 (12.1) 3.4 (3.1)      
completeness % 99.9 (99.3) 99.5 (97.2) 99.8 (99.1) 99.8 (98.5) 99.5 (96.7) 99.0 (97.5)      
R merge % 7.4 (96.3) 11.4 (78.6) 7.9 (98.8) 9.5 (89.4) 13.1 (81.5) 8.0 (88.0)      
CC (1/2) 99.9 (83.2) 99.8 (86.5) 99.9 (84.0) 99.8 (86.2) 99.7 (83.8) 99.7 (83.8)      
I/s(I) 17.62 (1.97) 14.29 (2.32) 16.63 (1.85) 14.83 (2.11) 10.28 (1.71) 9.70 (1.15)      
Refinement      
number of reflections (total/test) 66 738 (6544) 48 282 (4739) 66 083 (6516) 53 344 (5211) 44 026 (4112) 68 399 (6707)      
no. of atoms 2977 2995 3057 3074 2928 3985      
protein 2619 2665 2638 2634 2617 3480      
solvent 281 252 338 339 232 421      
ligand 77 78 81 101 79 84      
R work % 0.16 0.21 0.16 0.17 0.18 0.16      
R free % 0.19 0.24 0.20 0.20 0.21 0.20      
Ligand in Chain      
A thalidomide thalidomide thalidomide thalidomide thalidomide        
B 10a 12a 16b 20a thalidomide co-crystal with CBG      
C thalidomide thalidomide 16b thalidomide 20b        
PDB ID 6R18 6R1C 6R1W 6R19 6R1A 6R0Q